Austin D Williams

8PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples mothers and babies health and wellbeingRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 29, 2026
Adjuvant CDK4/6 inhibitors in early-stage breast cancer: Clinical evidence and considerations for risk stratification and treatment selection.

|Jan 01, 2025
Neoadjuvant Endocrine Therapy Compared to Neoadjuvant Chemotherapy in Node-Positive HR+, HER2- Breast Cancer (Nodal pCR and the Rate of ALND): A Systematic Review and Meta-Analysis.

Mahtab Vasigh, Mohammadreza Karoobi, Austin D Williams

|Nov 29, 2023
Should patients with hormone receptor-positive, HER2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib?

Austin D Williams, Karen Ruth, Saba S Shaikh

|Oct 21, 2022
Use of a supervised machine learning model to predict Oncotype DX risk category in node-positive patients older than 50 years of age.

Austin D Williams, Kate R Pawloski, Hannah Y Wen

|Jan 22, 2022
Racial and socioeconomic disparities in breast cancer diagnosis and mortality in Pennsylvania.

Austin D Williams, Meghan Buckley, Robin M Ciocca

|Feb 12, 2021
Comparison of open and minimally invasive approaches to colon cancer resection in compliance with 12 regional lymph node harvest quality measure.

Austin D Williams, Tian Sun, Sumedh Kakade

Pageof 2

Frequent Collaborators

1 joint publications

Sylvia A Reyes

1 joint publications

Stacy Ugras

1 joint publications

Mahmoud El-Tamer

1 joint publications

Mahtab Vasigh